 | Amicus Therapeutics, Inc. | |||
| NGM : FOLD || Location: United States | ||||
$10.54-0.17 (-1.59%) |
1.82 M | 10.5 - 10.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 32.489 M |
| March 15, 2024 | 32.399 M |
| Feb. 29, 2024 | 30.912 M |
| Feb. 15, 2024 | 26.781 M |
| Jan. 31, 2024 | 24.397 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.06 | -0.11 | -83.03% |
| 09/30/2023 | -0.08 | -0.07 | 9.21% |
| 06/30/2023 | -0.13 | -0.15 | -19.24% |
| 03/31/2023 | -0.15 | -0.18 | -20.32% |
| 12/31/2022 | -0.13 | -0.19 | -47.40% |
FOLD Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 295.383M | Shares Float | 222.119M |
| Short Float | 32.489M | Market Cap | 3163.55M |
| Institution ownership | 0.00% | Insider ownership | 0.751% |
| Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.51 | Forward EPS | 0.39 |